Fujifilm Biosciences Inc.

Santa Ana, CA Doing business as Fujifilm Irvine Scientific, Inc. Part of Fujifilm Holdings America Corp

UEI
NCTEKHZJ9293
CAGE
0KDR5
Primary NAICS
325414 Biological Product (except Diagnostic) Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Foreign Owned
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
Corporate family
SAM.gov registration date
Physical address
2501 Pullman St #201, Santa Ana, CA 92705, USA
Website
fujifilm.com
Founded
1934
Employees
10K-50K
Estimated annual revenue
$10B+
Industry
  1. Consumer Discretionary
  2. Consumer Durables & Apparel
  3. Household Durables
  4. Photography
SIC code
38 Instruments & Related Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Fujifilm Biosciences Inc.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
EO 14398 - purchase of human induced pluripotent stem cell-derived (hipsc) cells. Contract · 75F40126F19003 Food and Drug Administration $144,970
Purchase of human induced pluripotent stem cell-derived (hipsc) cells Contract · 75F40126F19002 Food and Drug Administration $15,133
Parts from kalypsys/GNF dispensers and viewlux, includes power supplies, nests, control boards Contract · 75N95C25P00120 National Center for Advancing Translational Sciences $21,500
Task order: human induced pluripotent stem cell-derived cells Contract · 75F40125F19001 Food and Drug Administration $246,980
Purchase of human induced pluripotent stem cell-derived (hipsc) cells Contract · 75F40125P00102 Food and Drug Administration $89,655

About Fujifilm Biosciences Inc.

Written by GovTribe AI ·

Fujifilm Biosciences Inc., doing business as Fujifilm Irvine Scientific, Inc., manufactures cell culture media, specialized research reagents, and hiPSC-derived cellular products that it sells to federal biomedical research agencies as a prime contractor on small firm-fixed-price purchase orders and delivery orders. The company is a foreign-owned, for-profit manufacturer headquartered in Santa Ana, California, and operates as a subsidiary of Fujifilm Holdings America Corp. (Valhalla, New York). Fujifilm Biosciences competes full-and-open across all recent federal work with no set-aside designations.

The customer base is concentrated in HHS biomedical research. The Food and Drug Administration dominates, accounting for 4 awards with $852 thousand in combined potential value across hiPSC cell procurement. The National Institutes of Health's National Institute of Environmental Health Sciences (3 awards, $86 thousand), the National Center for Advancing Translational Sciences (2 awards, $36 thousand), and the Army Medical Command (2 awards, $72 thousand) round out the active customer set. Across the full award population, HHS agencies hold 27% of award count but 99% of combined potential value, signaling tight concentration in civilian biomedical research markets. Recent representative work includes a $246,980 delivery order from FDA for hiPSC cells (September 2025), an $89,655 purchase order from FDA for hiPSC cells (July 2025), a $21,500 purchase order from the National Center for Advancing Translational Sciences for equipment parts and component extraction from discontinued lab equipment (September 2025), and a $15,133 delivery order from FDA for hiPSC cells issued June 1, 2026, under a single-award FDA Indefinite Delivery Contract valued at $500,000 and running through August 31, 2031.

Fujifilm Biosciences holds a single-award FDA Indefinite Delivery Contract (75F40125D00013) with a $500,000 ceiling and performance window through August 31, 2031, which anchors ongoing hiPSC cell procurement. Two task orders under this vehicle carry $262 thousand in combined potential value. Activity is sparse and episodic — one award in 2020, one in 2021, two in 2022, four in 2025, and one in 2026 — with combined potential value of $1.1 million across 48 historical prime awards and no subcontract footprint. Two awards totaling $262 thousand face completion within the next twenty-four months. The company's primary NAICS coding splits between Biological Product Manufacturing (9 awards) and In-Vitro Diagnostic Substance Manufacturing (3 awards), with PSC work concentrated in Laboratory Equipment and Supplies (17 awards) and Drugs and Biologicals (5 awards).

Quick answers

What is Fujifilm Biosciences Inc.'s UEI?

Fujifilm Biosciences Inc.'s Unique Entity ID (UEI) in SAM.gov is NCTEKHZJ9293.

What is Fujifilm Biosciences Inc.'s CAGE code?

Fujifilm Biosciences Inc.'s CAGE code is 0KDR5.

What is Fujifilm Biosciences Inc.'s primary NAICS code?

Fujifilm Biosciences Inc.'s primary NAICS code is 325414 (Biological Product (except Diagnostic) Manufacturing).

Where is Fujifilm Biosciences Inc. located?

Fujifilm Biosciences Inc.'s physical address in SAM.gov is 2501 Pullman St #201, Santa Ana, CA 92705, USA.

Is Fujifilm Biosciences Inc. registered in SAM.gov?

Yes. Fujifilm Biosciences Inc.'s SAM.gov registration is active through June 12, 2027.

Who is Fujifilm Biosciences Inc.'s parent company?

Fujifilm Biosciences Inc. is part of Fujifilm Holdings America Corp.

What is Fujifilm Biosciences Inc.'s most recent federal award?

Fujifilm Biosciences Inc.'s most recent federal contract award is EO 14398 - purchase of human induced pluripotent stem cell-derived (hipsc) cells (75F40126F19003), from Food and Drug Administration, on September 30, 2026.

On GovTribe

See Fujifilm Biosciences Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login